Javascript must be enabled to continue!
Pathophysiological Functions of the lncRNA TUG1
View through CrossRef
Background:
Long non-coding RNAs (lncRNAs) with little or no coding capacity are associated with
a plethora of cellular functions, participating in various biological processes. Cumulative study of lncRNA provides
explanations to the physiological and pathological processes and new perspectives to the diagnosis, prevention,
and treatment of some clinical diseases. Long non-coding RNA taurine-upregulated gene 1(TUG1) is one of
the first identified lncRNAs associated with human disease, which actively involved in various physiological
processes, including regulating genes at epigenetics, transcription, post-transcription, translation, and posttranslation.
The aim of this review was to explore the molecular mechanism of TUG1 in various types of human
diseases.
Methods:
In this review, we summarized and analyzed the latest findings related to the physiologic and pathophysiological
processes of TUG1 in human diseases. The related studies were retrieved and selected the last six
years of research articles in PubMed with lncRNA and TUG1 as keywords.
Results:
TUG1 is a valuable lncRNA that its dysregulated expression and regulating the biological processes
were found in a variety of human diseases. TUG1 is found to exhibit aberrant expression in a variety of malignancies.
Dysregulation of TUG1 has been shown to contribute to proliferation, migration, cell cycle changes,
inhibited apoptosis, and drug resistance of cancer cells, which revealed an oncogenic role for this lncRNA, but
some reports have shown downregulation of TUG1 in lung cancer samples compared with noncancerous samples.
In addition, the molecular and biological functions of TUG1 in physiology and disease (relevant to endocrinology,
metabolism, immunology, neurobiology) have also been highlighted. Finally, we discuss the limitations and
tremendous diagnostic/therapeutic potential of TUG1 in cancer and other diseases.
Conclusion:
Long non-coding RNA-TUG1 likely served as useful disease biomarkers or therapy targets and
effectively applied in different kinds of diseases, such as human cancer and cardiovascular diseases.
Bentham Science Publishers Ltd.
Title: Pathophysiological Functions of the lncRNA TUG1
Description:
Background:
Long non-coding RNAs (lncRNAs) with little or no coding capacity are associated with
a plethora of cellular functions, participating in various biological processes.
Cumulative study of lncRNA provides
explanations to the physiological and pathological processes and new perspectives to the diagnosis, prevention,
and treatment of some clinical diseases.
Long non-coding RNA taurine-upregulated gene 1(TUG1) is one of
the first identified lncRNAs associated with human disease, which actively involved in various physiological
processes, including regulating genes at epigenetics, transcription, post-transcription, translation, and posttranslation.
The aim of this review was to explore the molecular mechanism of TUG1 in various types of human
diseases.
Methods:
In this review, we summarized and analyzed the latest findings related to the physiologic and pathophysiological
processes of TUG1 in human diseases.
The related studies were retrieved and selected the last six
years of research articles in PubMed with lncRNA and TUG1 as keywords.
Results:
TUG1 is a valuable lncRNA that its dysregulated expression and regulating the biological processes
were found in a variety of human diseases.
TUG1 is found to exhibit aberrant expression in a variety of malignancies.
Dysregulation of TUG1 has been shown to contribute to proliferation, migration, cell cycle changes,
inhibited apoptosis, and drug resistance of cancer cells, which revealed an oncogenic role for this lncRNA, but
some reports have shown downregulation of TUG1 in lung cancer samples compared with noncancerous samples.
In addition, the molecular and biological functions of TUG1 in physiology and disease (relevant to endocrinology,
metabolism, immunology, neurobiology) have also been highlighted.
Finally, we discuss the limitations and
tremendous diagnostic/therapeutic potential of TUG1 in cancer and other diseases.
Conclusion:
Long non-coding RNA-TUG1 likely served as useful disease biomarkers or therapy targets and
effectively applied in different kinds of diseases, such as human cancer and cardiovascular diseases.
Related Results
Data from Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer
Data from Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer
<div>Abstract<p>Overcoming drug resistance is one of the biggest challenges in cancer chemotherapy. In this study, we examine whether targeting the long noncoding RNA t...
LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
Abstract
Objective: To examine the expression and function of long non-coding RNA taurine up-regulated 1 (TUG1) in human osteosarcoma cells. Methods: Real-time quant...
Long non-coding RNA taurine upregulated gene 1 is downregulated in osteoporosis and influences the osteogenic differentiation of bone marrow mesenchymal stem cells
Long non-coding RNA taurine upregulated gene 1 is downregulated in osteoporosis and influences the osteogenic differentiation of bone marrow mesenchymal stem cells
Background
With aging, an imbalance in bone remodeling leading to increased bone resorption and decreased bone formation is thought to contribute to osteoporosis. Os...
Long non-coding RNA (LncRNA) as a biomarker and therapeutic agent for cancer
Long non-coding RNA (LncRNA) as a biomarker and therapeutic agent for cancer
Long non-coding RNA (lncRNA) are transcripts of >200 nucleotides that do not translate into proteins. Once considered as a part of transcriptional noise, now with advanced genom...
Abstract 1778: MALAT1 and TUG1 long non-coding RNAs signalling mechanisms in response to SRPK1 inhibitor in prostate cancer
Abstract 1778: MALAT1 and TUG1 long non-coding RNAs signalling mechanisms in response to SRPK1 inhibitor in prostate cancer
Abstract
Introduction:
Prostate cancer (PCa) is a leading cause of cancer death, and there are significant racial disparities in...
Abstract A08: A novel lncRNA RGMB-AS inhibit NSCLC metastasis via upregulating the expression of target gene RGMB
Abstract A08: A novel lncRNA RGMB-AS inhibit NSCLC metastasis via upregulating the expression of target gene RGMB
Abstract
Background: The relationships between long noncoding RNA (lncRNAs) and tumors have currently become one of the focuses on cancer studies. Our previous studi...
Role Of Lncrna In Alzheimer’s Diseases
Role Of Lncrna In Alzheimer’s Diseases
Long noncoding RNA (lncRNA) are a family of RNA molecules with over 200 nucleotides in size. They cannot code for proteins but still have biological activities. lncRNAs are abundan...
Construction of a lncRNA-associated ceRNA network and identification of a potential six-lncRNA prognostic signature for esophageal cancer
Construction of a lncRNA-associated ceRNA network and identification of a potential six-lncRNA prognostic signature for esophageal cancer
Abstract
BACKGROUND: Mounting evidence has shown that long noncoding RNAs (lncRNAs) can function as competing endogenous RNAs (ceRNAs) which participate in the initiation a...

